Osteoporosis International

, Volume 14, Issue 12, pp 969–977

A comparison of different screening strategies to identify elderly women at high risk of hip fracture: results from the EPIDOS prospective study

  • P. Dargent-Molina
  • S. Piault
  • G. Bréart
  • EPIDOS Study Group
Original Article


Decision to treat with an anti-osteoporotic drug should be based on individual fracture risk evaluation. We compared the discriminant value of four different screening strategies to identify elderly women with a risk of hip fracture greater than 20 per 1000 woman-years: (1) BMD screening alone, (2) quantitative ultrasound (QUS) screening alone, (3) QUS triage followed by BMD assessment for women with medium-low QUS parameters, and (4) selective BMD screening based on weight followed by clinical evaluation for women with medium-low BMD. The study population included 5910 women aged 75 years or older who participated to the EPIDOS (Epidemiologie de l’Ostéoporose) prospective study. Over an average of 3.7 (±0.8) years of follow-up, 231 women suffered a hip fracture, which corresponds to an average risk of 10.6 per 1000 woman-years. All strategies allow us to clearly distinguish a group at high risk of hip fracture (i.e. >20 per 1000 woman-years) from a group at low risk (i.e. below the average risk in the cohort). QUS screening alone has a very low sensitivity (15%). The strategy using QUS as a method of triage and that combining selective BMD and clinical assessment have a sensitivity equivalent to systematic BMD screening (around 35%), with less than 50% BMD examinations. The high-risk women identified by these two strategies are not the same. A simple algorithm combining QUS, BMD, and clinical risk assessment allows an increased number of high-risk women to be identified (21%), and thus improves the sensitivity (53%). With this combined strategy, women in the high-risk group have one chance in ten of having a hip fracture over the next 4 years, whereas women in the low risk group have only one chance in 40.


Hip fracture Osteodensitometry Osteoporosis Risk factors Screening Ultrasound 


  1. 1.
    Delmas PD (2002) Treatment of postmenopausal osteoporosis. Lancet 359:2018–2026CrossRefPubMedGoogle Scholar
  2. 2.
    Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929–1936CrossRefPubMedGoogle Scholar
  3. 3.
    Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254–1259PubMedGoogle Scholar
  4. 4.
    Kanis JA, Black D, Cooper C et al. (2002) A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int 13:527–536CrossRefGoogle Scholar
  5. 5.
    Jonsson B, Kanis J, Dawson A, Oden A, Johnell O (1999) Effect and offset of effect of treatments for hip fracture on health outcomes. Osteoporos Int 10:193–199CrossRefPubMedGoogle Scholar
  6. 6.
    Dargent-Molina P, Poitiers F, Bréart G (2000) In elderly women weight is the best predictor of a vey low bone mineral density: evidence from the EPIDOS study. Osteoporos Int 11:881–888CrossRefPubMedGoogle Scholar
  7. 7.
    Dargent-Molina P, Douchin MN, Cormier C, Meunier PJ, Bréart G (2002) Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: the EPIDOS prospective study. Osteoporos Int 13:593–599CrossRefGoogle Scholar
  8. 8.
    Glüer CC, Hans D (1999) How to use ultrasound for risk assessment: a need for defining strategies. Osteoporos Int 9:193–195CrossRefPubMedGoogle Scholar
  9. 9.
    Torgerson DJ (1998) Is there a future for non-menopausal screening strategeis for osteoporosis prevention? Osteoporos Int Suppl. 1:S57–S61Google Scholar
  10. 10.
    Dargent-Molina P, Favier F, Grandjean H et al. (1996) Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet 348:145–149PubMedGoogle Scholar
  11. 11.
    Hans D, Dargent-Molina P, Schott AM et al. (1996) Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 348:511–514PubMedGoogle Scholar
  12. 12.
    Black DM, Cummings SR, Karpf DB et al. (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535–1541PubMedGoogle Scholar
  13. 13.
    Cummings SR, Black DM, Thompson DE et al. (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the Fracture Intervention Trial. JAMA 280:2077–2082PubMedGoogle Scholar
  14. 14.
    McClung MR, Geusens P, Miller PD et al. (2001) Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344:333–340CrossRefPubMedGoogle Scholar
  15. 15.
    Neer RM, Arnaud CD, Zanchetta JR et al. (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441PubMedGoogle Scholar
  16. 16.
    Glüer CC (1997) Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. J Bone Miner Res 12:1280–1288PubMedGoogle Scholar
  17. 17.
    Gonnelli S, Cepollaro C, Montagnani A et al. (2002) Heel ultrasonography in monitoring alendronate therapy: a four-year longitudinal study. Osteoporos Int 13:415–421CrossRefGoogle Scholar
  18. 18.
    Cummings SR, Palermo L, Browner WS et al. (2000) Monitoring osteoporosis therapy with bone densitometry. JAMA 283:1318–1321CrossRefPubMedGoogle Scholar
  19. 19.
    Chapuy MC, Schott AM, Garnero P, Hans D, Delmas PD, Meunier PJ, and the EPIDOS Study Group (1996) Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. J Clin Endocrinol Metab 81:1129–1133PubMedGoogle Scholar
  20. 20.
    Scharla SH (1998) Prevalence of subclinical vitamin D deficiency in different European countries. Osteoporos Int Suppl 8:S7–S12Google Scholar
  21. 21.
    Bauer DC, Glüer CC, Cauley JA et al. (1997) Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. Arch Int Med 157:629–634CrossRefGoogle Scholar
  22. 22.
    Lydick E, Cook K, Turpin J et al. (1998) Development and validation of a simple questionnaire to facilitate identification of women likely to have a low bone density. Am J Managed Care 4:37–48Google Scholar
  23. 23.
    Cadetta SM, Jagal SB, Kreiger N et al. (2000) Development and validation of the osteoporosis risk assessment instrument to facilitate selection of women for bone densitometry. Can Med Assoc J 162:1289–1294Google Scholar
  24. 24.
    Burger H, De Laet C, Weel A, Hofman A, Pols H (1999) Added value of bone mineral density in hip fracture risk scores. Bone 25:369–374CrossRefPubMedGoogle Scholar
  25. 25.
    Koh LKH, Ben Sedrine W, Torralba TP et al. (2001) A simple tool to identify Asian women at increased risk of osteoporosis. Osteoporos Int 12:699–705CrossRefPubMedGoogle Scholar
  26. 26.
    Black DM, Steinbuch M, Palermo L, Dargent-Molina P, Lindsay R, Hoseyni MS, Johnell O (2001) An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 12:519–528CrossRefGoogle Scholar
  27. 27.
    McGrother CW, Donaldson MMK, Clayton D, Abrams KR, Clarke M (2002) Evaluation of a hip fracture risk score for assessing elderly women: the Melton Osteoporotic Fracture (MOF) study. Osteoporos Int 13:89–96CrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2003

Authors and Affiliations

  • P. Dargent-Molina
    • 1
  • S. Piault
    • 1
  • G. Bréart
    • 1
  • EPIDOS Study Group
  1. 1.INSERM (Institut National de la Santé et de la Recherche Médicale)Villejuif CedexFrance

Personalised recommendations